SCHEMBL18308761

SCHEMBL18308761

Cc1ccc(-c2ccc(-c3ccc(P)cc3C)cc2)c(C)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR2 Q92731 2/20 0.40
▸ ESR1 P03372 1/20 0.40
▸ NPC1 O15118 2/20 0.39
▸ RAB9A P51151 2/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ MAPT P10636 3/20 0.39
▸ GAA P10253 1/20 0.39
▸ HSD17B1 P14061 1/20 0.37
▸ TP53 P04637 2/20 0.37
▸ TDP1 Q9NUW8 2/20 0.37
▸ CA1 P00915 1/20 0.36
▸ CA2 P00918 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ MAOB P27338 2/20 0.33
▸ MAOA P21397 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ ALPL P05186 1/20 0.33
▸ CA9 Q16790 1/20 0.33
▸ ADORA3 P0DMS8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18308734 0.94 ESR2 (0.39) ESR2ESR1NPC1RAB9AMEN1
SCHEMBL18308741 0.94 ESR2 (0.41) ESR2ESR1NPC1RAB9AMEN1
SCHEMBL18308791 0.92 ESR2 (0.38) ESR2ESR1NPC1RAB9AMEN1
SCHEMBL18308787 0.92 ESR2 (0.40) ESR2ESR1NPC1RAB9AMEN1
SCHEMBL18308749 0.91 ESR2 (0.43) ESR2ESR1HSD17B1TDP1CA1
SCHEMBL18308740 0.89 ESR2 (0.42) ESR2ESR1HSD17B1TDP1CA1
SCHEMBL18308754 0.87 ESR2 (0.41) ESR2ESR1HSD17B1TDP1ALDH1A1
SCHEMBL18308794 0.86 MAPT (0.39) ESR2ESR1NPC1RAB9AMEN1
SCHEMBL284409 0.84 ESR2 (0.47) ESR2ESR1NPC1RAB9AMEN1
SCHEMBL18722306 0.82 ESR2 (0.45) ESR2ESR1NPC1RAB9AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11718791-B2 Polymerisable compounds and the use thereof in liquid-crystal displays MERCK PATENT GMBH (DE) 2023-08-08 — — US disclosed
US-20170121606-A1 POLYMERIZABLE COMPOUNDS AND THE USE THEREOF IN LIQUID-CRYSTAL DISPLAYS GMBH, MERCK PATENT (DE) 2017-05-04 — — US disclosed
US-20160362606-A1 POLYMERIZABLE COMPOUNDS AND THE USE THEREOF IN LIQUID-CRYSTAL DISPLAYS MERCK PATENT GMBH (DE) 2016-12-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11718791-B2 Polymerisable compounds and the use thereof in liquid-crystal displays VCL, ILK, LCP1 ESR2 4146/4885ESR1 2744/4885NPC1 3297/4885
US-20170121606-A1 POLYMERIZABLE COMPOUNDS AND THE USE THEREOF IN LIQUID-CRYSTAL DISPLAYS VCL, LCP1, MAP1LC3C ESR2 4322/4885ESR1 2626/4885NPC1 3440/4885
US-20160362606-A1 POLYMERIZABLE COMPOUNDS AND THE USE THEREOF IN LIQUID-CRYSTAL DISPLAYS VCL, PLEC, EML4 ESR2 4381/4885ESR1 3527/4885NPC1 3628/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback